Search Results for 'Nsclc Advanced'

Nsclc Advanced published presentations and documents on DocSlides.

SW GLH services for NSCLC – An update

SW GLH services for NSCLC – An update

by everly

Professor Rachel Butler. The genomic complexity of...

NSCLC with high PD-L1 expression on tumor cells or tumor-infiltrating immune cells represents disti

NSCLC with high PD-L1 expression on tumor cells or tumor-infiltrating immune cells represents disti

by sawyer742

Intervista a Federico . Cappuzzo. Background:. Pr...

by luanne-stotts

Brada. . Torino. . 6 March 2015. Perspectives...

MEK Inhibitors and their potential role in relapsed NSCLC

MEK Inhibitors and their potential role in relapsed NSCLC

by debby-jeon

Ranee Mehra, MD. Fox Chase Cancer Center. Philade...

by cheryl-pisano

Le Chevalier, . MD. The Role of Translational Res...

Using Non-targeted Therapies in Targeted Lung Cancer Popula

Using Non-targeted Therapies in Targeted Lung Cancer Popula

by ellena-manuel

Nathan Pennell, M.D., Ph.D.. September 6, 2014. O...

NSCLC with high PD-L1 expression on tumor cells or tumor-in

NSCLC with high PD-L1 expression on tumor cells or tumor-in

by test

Intervista a Federico . Cappuzzo. Background:. P...

by pasty-toler

MD. The Evolving Treatment Landscape in NSCLC: Co...

by jane-oiler

of the expression of . 17-beta-hydroxysteroid . ...

EGFR-Mutated NSCLC and CNS Involvement: the Conundrum

EGFR-Mutated NSCLC and CNS Involvement: the Conundrum

by pasty-toler

This program will include a discussion of off-lab...

The Role of Antiangiogenic Agents

The Role of Antiangiogenic Agents

by luanne-stotts

The Role of Antiangiogenic Agents in the Changin...

The Cancer genome atlas (TCGA) and the search for a CUP genetic/epigenetic signature

The Cancer genome atlas (TCGA) and the search for a CUP genetic/epigenetic signature

by stefany-barnette

The Cancer genome atlas (TCGA) and the search for...

Please note, these are the

Please note, these are the

by disclaimercanon

actual. . video-recorded proceedings from the . l...

Please note, these are the actual video-recorded

Please note, these are the actual video-recorded

by chaptoe

proceedings from the live CME event and may includ...

NSCLC: Epidemiology and disease characteristics

NSCLC: Epidemiology and disease characteristics

by scarlett

NSCLC, non-small cell lung cancer.. Lung cancer in...

Multidisciplinary approach to lung cancer

Multidisciplinary approach to lung cancer

by elena

Kamil Konopka. Department of Oncology, University ...

Consensus or Controversy?

Consensus or Controversy?

by okelly

Addressing Practical Clinical Questions Across the...

Integration of Immunotherapy Across

Integration of Immunotherapy Across

by karlyn-bohler

the Spectrum of Lung Cancer. Karen Kelly, MD. Pro...

Slides last updated:

Slides last updated:

by calandra-battersby

October 2013. There are two main types of lung . ...

Lung malignancy

Lung malignancy

by tawny-fly

Dr. Rachel Cary, FY1 Warwick Hospital. Learning ...

Targeting KRAS and down streaming

Targeting KRAS and down streaming

by alexa-scheidler

pathways. Federico Cappuzzo. Istituto Toscano Tum...

by min-jolicoeur

targeted. : . limiti e successi nelle metastasi ...

Detection of Mutations in EGFR in Circulating Lung-Cancer C

Detection of Mutations in EGFR in Circulating Lung-Cancer C

by sherrill-nordquist

Colin Reisterer and Nick Swenson. S. . Maheswaran...

by alida-meadow

treatments. in WT . pts. : . which. . opportuni...

Slides last updated:

Slides last updated:

by stefany-barnette

October 2013 . Ferlay . J, Shin HR, Bray F, Forma...

Integration of Immunotherapy Across

Integration of Immunotherapy Across

by pamella-moone

the Spectrum of Lung Cancer. Karen Kelly, MD. Pro...

Italian cohort of

Italian cohort of

by test

nivolumab. Expanded Access . Programme. (EAP): ...

Minesh Mehta, Northwestern University

Minesh Mehta, Northwestern University

by mitsue-stanley

Chicago, IL. Radiation for Prevention and Treatme...

Optimal treatment for elderly patients with NSCLC

Optimal treatment for elderly patients with NSCLC

by cheryl-pisano

Giorgio V. Scagliotti. University. of . Torino,....

L’algoritmo terapeutico

L’algoritmo terapeutico

by calandra-battersby

attraverso . i . c. asi clinici. Giuseppe . Valma...

Estimated costs of managing treatment-related adverse

Estimated costs of managing treatment-related adverse

by lindy-dunigan

eventsof. . nivolumab. and . docetaxel. in the...

Low TPS High TPS TPS = PD-L1 tumor proportion score Low TPS = 10%; high TPS = 60%

Low TPS High TPS TPS = PD-L1 tumor proportion score Low TPS = 10%; high TPS = 60%

by olivia-moreira

Low TPS High TPS TPS = PD-L1 tumor proportion sco...

ASCO 2019 NSCLC - PARP & Chemotherapy

ASCO 2019 NSCLC - PARP & Chemotherapy

by mitsue-stanley

ASCO 2019 NSCLC - PARP & Chemotherapy REF Stu...

OMICS International welcomes submissions that are original and technically so as to serve both th

OMICS International welcomes submissions that are original and technically so as to serve both th

by lois-ondreau

OMICS Journals are poised in excellence by publi...

Lung cancer Treatment

Lung cancer Treatment

by attentionallianz

Consequences of the Lack of Patients of color &...

Module 13: Targeted Treatment

Module 13: Targeted Treatment

by disclaimercanon

of Lung Cancer . Wendi S Lee, MSN, RN, NP-C. Anne ...

Please note, these are the

Please note, these are the

by vizettan

actual. . video-recorded proceedings from the . l...

NA_00092076/ J1414, Protocol Version 4.8 Dated 13November2018

NA_00092076/ J1414, Protocol Version 4.8 Dated 13November2018

by singh

1 Study Title: Neoadjuvant Nivolumab, or Nivoluma...

Presented at the European Society for Medical Oncology 2019 Barcelona

Presented at the European Society for Medical Oncology 2019 Barcelona

by lucy

– 1 October, 2019 ● GSK 3377794 activate and i...

Instructions for Use of These Slides

Instructions for Use of These Slides

by carla

The purpose of these slides is to serve as a resou...